These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 33493421
1. Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis. Lu Q, Chen W, Ji Y, Liu Y, Xue X. Cancer Biother Radiopharm; 2022 Oct; 37(8):673-683. PubMed ID: 33493421 [Abstract] [Full Text] [Related]
2. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis. Du C, Wang Y, Zhang Y, Zhang J, Zhang L, Li J. Cell Transplant; 2020 Oct; 29():963689720929983. PubMed ID: 32686982 [Abstract] [Full Text] [Related]
3. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy. Zheng S, Fu W, Huang Q, Zhou J, Lu K, Gu J, Ma R, Guo G. Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923 [Abstract] [Full Text] [Related]
4. Long non-coding ribonucleic acid zinc finger E-box binding homeobox 1 antisense RNA 1 regulates myocardial fibrosis in diabetes through the Hippo-Yes-associated protein signaling pathway. Wu J, Lyu R, Chen S, Wang X. J Diabetes Investig; 2023 Aug; 14(8):940-952. PubMed ID: 37309277 [Abstract] [Full Text] [Related]
5. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H. Cancer Biol Ther; 2018 Jul 03; 19(7):573-583. PubMed ID: 29667486 [Abstract] [Full Text] [Related]
6. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA. Luo N, Zhang K, Li X, Hu Y. J Cell Biochem; 2020 Oct 03; 121(10):4176-4187. PubMed ID: 31922280 [Abstract] [Full Text] [Related]
7. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway. Qiao Y, Wang B, Yan Y, Niu L. Environ Toxicol; 2022 Oct 03; 37(10):2398-2411. PubMed ID: 35730485 [Abstract] [Full Text] [Related]
8. LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p/RBM39 axis. Wang Y, Wang X, Sun H, Zhang Z, Gu J. Mol Cell Biochem; 2024 Mar 12. PubMed ID: 38472681 [Abstract] [Full Text] [Related]
9. Long noncoding RNA ZEB1-AS1 attenuates ferroptosis of gastric cancer cells through modulating miR-429/BGN axis. Wu C, Hou X, Li S, Luo S. J Biochem Mol Toxicol; 2023 Aug 12; 37(8):e23381. PubMed ID: 37128782 [Abstract] [Full Text] [Related]
10. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway. Zhu S, Sun J, Liu X, Shao H, Feng C, Wang Z, Zheng X, Wei S. Mol Cell Biol; 2022 Jun 16; 42(6):e0018821. PubMed ID: 35499320 [Abstract] [Full Text] [Related]
11. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer. Wu J, Xu W, Ma L, Sheng J, Ye M, Chen H, Zhang Y, Wang B, Liao M, Meng T, Zhou Y, Chen H. Aging (Albany NY); 2021 Jul 21; 13(14):18191-18222. PubMed ID: 34289449 [Abstract] [Full Text] [Related]
12. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R, Huang Z, Qian C, Wang M, Zheng Y, Jiang R, Yu C. Biochem Biophys Res Commun; 2020 Jun 11; 526(4):1005-1012. PubMed ID: 32307083 [Abstract] [Full Text] [Related]
13. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T, Liu Y, Li B. IUBMB Life; 2019 Oct 11; 71(10):1537-1551. PubMed ID: 31188543 [Abstract] [Full Text] [Related]
14. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1. Selem NA, Nafae H, Manie T, Youness RA, Gad MZ. Pathol Res Pract; 2023 Aug 11; 248():154579. PubMed ID: 37301086 [Abstract] [Full Text] [Related]
15. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54. Liu B, Yao P, Xiao F, Guo J, Wu L, Yang Y. J Transl Med; 2021 Aug 05; 19(1):333. PubMed ID: 34353336 [Abstract] [Full Text] [Related]
16. Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis. Li Y, Lv M, Song Z, Lou Z, Wang R, Zhuang M. Biomed Pharmacother; 2018 Jul 05; 103():939-946. PubMed ID: 29710510 [Abstract] [Full Text] [Related]
17. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c. Xue S, Lu F, Sun C, Zhao J, Zhen H, Li X. World J Surg Oncol; 2021 Apr 17; 19(1):121. PubMed ID: 33865414 [Abstract] [Full Text] [Related]
18. HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells. Chi C, Mao M, Shen Z, Chen Y, Chen J, Hou W. Hum Gene Ther; 2018 Dec 17; 29(12):1438-1448. PubMed ID: 29896986 [Abstract] [Full Text] [Related]
19. Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis. Qian J, Lei X, Sun Y, Zheng L, Li J, Zhang S, Zhang L, Li W, Shi J, Jia W, Tang T. Biol Direct; 2021 Aug 06; 16(1):13. PubMed ID: 34362407 [Abstract] [Full Text] [Related]
20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W. Theranostics; 2019 Aug 06; 9(7):2036-2055. PubMed ID: 31037155 [Abstract] [Full Text] [Related] Page: [Next] [New Search]